In a groundbreaking clinical trial, a 66-year-old Ohio woman became the first patient to become cancer free through the CAR T Cell Therapy. In August this year, Denise Kennan had participated in th...
In what could be regarded as a precursor to a new mode of cancer diagnosis, an artificial intelligence based tool, developed at the Osaka University in Japan, can precisely differentiate between different cancer cells, paving the way for automated determination of appropriate individualized cancer treatments. As a m...
Find More
Gold nanoparticles may soon turn out to be a Prostate cancer treatment option. Apparently, there are certain risks associated with conventional cancer treatments such as uncontrolled bleeding, fatal blood clots and dangerous reactions to the anaesthetic, among others. To relieve patients from such risks, a new clini...
Find More
The world of cancer cells is bewildering, very difficult in understanding. The behaviour of cancer cells is not only complex but also intriguing. Research has been unfolding mystery after mystery of the complex world of cancer cells, shedding more and more light into the mysterious nature of cancer cells. In a new t...
Find More
If dementia genes are found, drug discovery can be accelerated in brain disorders The overproduction of a protein called tau has been detected in the neuron degeneration that causes Alzheimer’s and other forms of dementia. But the exact genetic process that causes tau is still a mystery. Scientists of the University...
Find More
It is needless to mention that the tug-of-war between cancer and researchers has been growing stronger and stronger. On one side, cancer has positioned itself as a leading cause of death and on the other side, scientists have been working diligently to find out more effective cancer treatments. According to the Amer...
Find More
It is needless to mention that Chemotherapy has been the most dependable cancer therapy. But, a new area of research shows the possibility of technology taking over the role of dominant cancer therapy in the future and in the event of which chemotherapy will be pushed to redundancy, as speculated. There is an ongoin...
Find More
Cambrex takes over Avista in USD 250 Million agreement Cambrex, life sciences company, is taking over Avista Pharma Solutions with a deal of USD 250 million to become a leading contract development and manufacturing organization (CDMO). The agreement includes the early-stage drug development and manufacturing capabi...
Find More
Actinic keratosis (AK) is a chronic and prevalent disease affecting areas of sun-exposed skin where visible and subclinical, non-visible lesions coexist. AK lesions are being represented as small scaly patches that can be flat or slightly raised. Their colour can range from one’s skin tone to a reddish-brown colour....
Find More
Preclinical biotech Synthorx needs a USD 100 Million IPO The early-stage Synthorx needs USD 100 million IPO. A while ago, La Jolla, California-based biotech got off a USD 63 million series C, but now wants a USD 100 million from an IPO to progress its pipelines of synthetic cytokines, which are designed to improve ...
Find More
Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....
Find More
Hemophilia, a genetic bleeding disorder characterized by a clotting factor protein deficiency. Intak.....
Find More
Intra-Tumoral Cancer Therapy refers to any therapy that is delivered in very close anatomical proxim.....
Find More
An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as .....
Find More
Atopic Dermatitis is a chronic inflammatory disease of the skin, which causes the skin to turn red a.....
Find More
Market intelligence (MI) is described as the information or the data derived by a company from the m.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
